STRIDES PHARMA SCIENCE Surges by 6%; BSE HEALTHCARE Index Up 1.4%
April 23, 2020 12:50 PM

STRIDES PHARMA SCIENCE share price has zoomed 6% and is presently trading at Rs 353.

Meanwhile, the BSE HEALTHCARE Index is at 15,440 (up 1.4%).

Among the top Gainers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (up 5.5%) and PFIZER (up 5.4%).

DR. REDDYS LAB (down 0.1%) and BIOCON (down 0.3%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved down from Rs 476 to Rs 353, registering a loss of Rs 123 (down 25.9%).

On the other hand, the BSE HEALTHCARE has moved up from 14,308 to 15,440, registering a gain of 1,132 points (up 7.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 115.4%), J.B.CHEMICALS (up 63.7%) and IPCA LABS (up 58.3%).

What About the Benchmark Indices?

The BSE Sensex is at 31,849 (up 1.4%).

The top gainers among the BSE Sensex stocks today are KOTAK MAHINDRA BANK (up 6.3%), ICICI BANK (up 4.4%) and TCS (up 4.3%). Other gainers include ONGC (up 3.7%) and BAJAJ FINANCE (up 3.0%). The most traded stocks in the BSE Sensex are ONGC and ICICI BANK.

In the meantime, NSE Nifty is at 9,326 (up 1.5%). The top gainers in the NSE Nifty include ZEE ENTERTAINMENT (up 7.5%), KOTAK MAHINDRA BANK (up 6.6%) and ICICI BANK (up 4.5%). Other gainers include TCS (up 4.4%) and HINDALCO (up 3.7%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,645 to 31,849, registering a loss of 6,796 points (down 17.63%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit stood at Rs 1 billion for the quarter ended December 2019, compared to a profit of Rs 316 million a year ago. Net Sales declined 7.8% to Rs 7.3 billion during the period as against Rs 7.9 billion in October-December 2018.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 8.4x.